<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04220502</url>
  </required_header>
  <id_info>
    <org_study_id>WayneMed</org_study_id>
    <nct_id>NCT04220502</nct_id>
  </id_info>
  <brief_title>Magic Shave Powder Gold's Affects on the Occurrence of Pseudofolliculitis Barbae</brief_title>
  <official_title>Depilatory Cream's Affect on the Occurrence of Pseudofolliculitis Barbae</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wayne State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wayne State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing the amount of papules, macules, pustules, and irritation caused by
      pseudofolluculitis barbae in subjects using depilatory cream versus traditional shaving
      methods.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparing an experimental group that will remove facial hair with magic shave powder gold,
      and a control group that will continue using traditional shaving methods. Both the subject
      and a physician will make observations to determine the efficacy of depilatory creams in
      reducing pseudofolliculits barbae.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Comparing an experimental to control group</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Single blinded study where investigator does not know what method of facial hair removal subjects have used</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Investigator Global Assessment</measure>
    <time_frame>12 weeks</time_frame>
    <description>Difference in the investigator assessment of lesions and irritation at baseline and 12 weeks, measured by investigator. The scale title is Investigator Global Assessment, the minimum value is 0, the maximum is 5. Higher scores mean worse outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Global Assessment</measure>
    <time_frame>12 weeks</time_frame>
    <description>Difference in the investigator assessment of disease symptoms at baseline and 12 weeks, measured by patient. The scale title is Patient Global Assessment, the minimum value is 0, the maximum is 5. Higher scores mean worse outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pseudofolliculitis Barbae</condition>
  <arm_group>
    <arm_group_label>Magic Shave Powder Gold</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive magic shaving powder gold and instructions on how to apply it. They will keep a log for their facial hair removal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional Methods</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This group will continue using traditional razors with the standard of care directions to shave. They will keep a log of their facial hair removal</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magic Shave Powder Gold</intervention_name>
    <description>Depilatory Cream for facial hair removal</description>
    <arm_group_label>Magic Shave Powder Gold</arm_group_label>
    <other_name>Experimental</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Traditional Shaving Methods</intervention_name>
    <description>Continued facial hair removal using traditional razors</description>
    <arm_group_label>Traditional Methods</arm_group_label>
    <other_name>Control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  PFB patient

        Exclusion Criteria:

          -  Failed sensitivity testing
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Daveluy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wayne State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rami M Youssef, BS</last_name>
    <phone>2487671300</phone>
    <email>rami.youssef@med.wayne.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samaa Alkhouri, BS</last_name>
    <phone>2487074401</phone>
    <email>samaa.alkhouri@med.wayne.edu</email>
  </overall_contact_backup>
  <reference>
    <citation>Daniel A, Gustafson CJ, Zupkosky PJ, Candido A, Kemp HR, Russell G, McMichael A. Shave frequency and regimen variation effects on the management of pseudofolliculitis barbae. J Drugs Dermatol. 2013 Apr;12(4):410-8.</citation>
    <PMID>23652888</PMID>
  </reference>
  <results_reference>
    <citation>Kindred C, Oresajo CO, Yatskayer M, Halder RM. Comparative evaluation of men's depilatory composition versus razor in black men. Cutis. 2011 Aug;88(2):98-103.</citation>
    <PMID>21916277</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 3, 2020</study_first_submitted>
  <study_first_submitted_qc>January 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2020</study_first_posted>
  <last_update_submitted>January 11, 2020</last_update_submitted>
  <last_update_submitted_qc>January 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wayne State University</investigator_affiliation>
    <investigator_full_name>Steven D Daveluy</investigator_full_name>
    <investigator_title>Fellow of the American Academy of Dermatology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hair Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

